#BEGIN_DRUGCARD DB03355

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C14H21N7O8S

# Chemical_IUPAC_Name:
(2R,3R)-2-amino-1-[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}sulfonyl)amino]-3-hydroxybutan-1-one

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine

# HET_ID:
TSB

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C14H21N7O8S/c1-5(22)7(15)13(25)20-30(26,27)28-2-6-9(23)10(24)14(29-6)21-4-19-8-11(16)17-3-18-12(8)21/h3-7,9-10,14,22-24H,2,15H2,1H3,(H,20,25)(H2,16,17,18)/t5-,6+,7-,9+,10-,14-/m1/s1

# InChI_Key:
InChIKey=UPVAPSGKXAAHBG-UWYIUFELSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3355

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
447.424

# Molecular_Weight_Mono:
447.117231373

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1EVL

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.5

# Predicted_LogS:
-1.9

# Predicted_Water_Solubility:
5.12e+00 g/l

# Primary_Accession_No:
DB03355

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936651

# PubChem_Substance_ID:
46506859

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03121

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
C[C@@H](O)[C@@H](N)C(=O)NS(=O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:10 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE005674

# Drug_Target_1_GenBank_ID_Protein:
24051829

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
thrS

# Drug_Target_1_Gene_Sequence:
>1929 bp
ATGCCTGTTATAACTCTTCCTGATGGCAGCCAACGCCATTACGACCACGCTGTAAGCCCC
ATGGATGTTGCGCTGGACATTGGTCCAGGTCTGGCGAAAGCCTGTATCGCAGGGCGCGTT
AATGGCGAACTGGTTGATGCTTGCGATCTGATTGAAAACGACGCACAACTGTCGATCATT
ACCGCCAAAGACGAAGAAGGTCTGGAGATCATTCGTCACTCCTGTGCGCACCTGTTAGGG
CATGCGATTAAACAACTTTGGCCGCATACCAAAATGGCAATCGGCCCGGTTATTGACAAC
GGTTTTTATTACGACGTTGATCTTGACCGCACGTTAACCCAGGAAGATGTCGAAGCACTC
GAGAAGCGGATGCATGAGCTTGCTGAGAAAAACTACGACGTCATTAAGAAGAAAGTCAGC
TGGCACGAAGCGCGTGAAACTTTCGCCAACCGTGGGGAGAGCTACAAAGTTTCCATTCTT
GACGAAAACATCGCCCATGATGACAAGCCAGGTCTGTACTTCCATGAAGAATATGTCGAT
ATGTGCCGCGGTCCGCACGTACCGAACATGCGTTTCTGCCATCATTTCAAACTAATGAAA
ACGGCAGGGGCTTACTGGCGTGGCGACAGCAACAACAAAATGTTGCAACGTATTTACGGT
ACGGCGTGGGCAGACAAAAAAGCACTTAACGCTTACCTGCAGCGCCTGGAAGAAGCCGCG
AAACGCGACCACCGTAAAATCGGTAAACAGCTCGACCTGTACCATATGCAGGAAGAAGCG
CCGGGTATGGTATTCTGGCACAACGACGGCTGGACCATCTTCCGTGAACTGGAAGTGTTT
GTTCGTTCTAAACTGAAAGAGTACCAGTATCAGGAAGTTAAAGGTCCGTTCATGATGGAC
CGTGTCCTGTGGGAAAAAACCGGTCACTGGGACAACTACAAAGATGCAATGTTCACCACA
TCTTCTGAGAACCGTGAATACTGCATTAAGCCGATGAACTGCCCGGGTCACGTACAAATT
TTCAACCAGGGGCTGAAGTCTTATCGCGATCTGCCGCTGCGTATGGCCGAGTTTGGTAGC
TGCCACCGTAACGAGCCGTCAGGTTCGCTGCATGGCCTGATGCGCGTGCGTGGATTTACC
CAGGATGACGCGCATATCTTCTGTACTGAAGAACAAATTCGCGATGAAGTTAACGGATGT
ATCCGTTTAGTCTATGATATGTACAGCACTTTTGGCTTCGAGAAGATCGTCGTCAAACTC
TCCACTCGTCCTGAAAAACGTATTGGCAGCGACGAAATGTGGGATCGTGCTGAGGCGGAC
CTGGCGGTTGCGCTGGAAGAAAACAACATCCCGTTTGAATATCAACTGGGTGAAGGCGCT
TTCTACGGTCCGAAAATTGAATTTACCCTGTATGACTGCCTCGATCGTGCATGGCAGTGC
GGTACAGTACAGCTGGACTTCTCCTTGCCGTCTCGTCTGAGCGCCTCCTATGTGGGCGAA
GACAACGAGCGTAAGGTACCGGTAATGATTCACCGCGCAATTCTGGGGTCGATGGAGCGT
TTCATCGGTATCCTGACCGAAGAATTCGCTGGTTTCTTCCCGACCTGGCTTGCGCCAGTT
CAGGTTGTTATCATGAATATTACCGATTCACAGTCTGAATACGTTAACGAATTGACGCAA
AAACTATCAAATGCGGGCATTCGTGTTAAAGCAGACTTGAGAAATGAGAAGATTGGCTTT
AAAATCCGCGAGCACACTTTGCGTCGCGTCCCATATATGCTGGTCTGTGGTGATAAAGAG
GTGGAATCAGGCAAAGTTGCCGTTCGCACCCGCCGTGGTAAAGACCTGGGAAGCATGGAC
GTAAATGAAGTGATCGAGAAGCTGCAACAAGAGATTCGCAGCCGCAGTCTTAAACAATTG
GAGGAATAA

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
12384590	Jin Q, Yuan Z, Xu J, Wang Y, Shen Y, Lu W, Wang J, Liu H, Yang J, Yang F, Zhang X, Zhang J, Yang G, Wu H, Qu D, Dong J, Sun L, Xue Y, Zhao A, Gao Y, Zhu J, Kan B, Ding K, Chen S, Cheng H, Yao Z, He B, Chen R, Ma D, Qiang B, Wen Y, Hou Y, Yu J: Genome sequence of Shigella flexneri 2a: insights into pathogenicity through comparison with genomes of Escherichia coli K12 and O157. Nucleic Acids Res. 2002 Oct 15;30(20):4432-41.
12704152	Wei J, Goldberg MB, Burland V, Venkatesan MM, Deng W, Fournier G, Mayhew GF, Plunkett G 3rd, Rose DJ, Darling A, Mau B, Perna NT, Payne SM, Runyen-Janecky LJ, Zhou S, Schwartz DC, Blattner FR: Complete genome sequence and comparative genomics of Shigella flexneri serotype 2a strain 2457T. Infect Immun. 2003 May;71(5):2775-86.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2877

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
74015

# Drug_Target_1_Name:
Threonyl-tRNA synthetase

# Drug_Target_1_Number_of_Residues:
642

# Drug_Target_1_PDB_ID:
1QF6

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00587	tRNA-synt_2b
PF02824	TGS
PF03129	HGTP_anticodon
PF07973	tRNA_SAD

# Drug_Target_1_Protein_Sequence:
>Threonyl-tRNA synthetase
MPVITLPDGSQRHYDHAVSPMDVALDIGPGLAKACIAGRVNGELVDACDLIENDAQLSII
TAKDEEGLEIIRHSCAHLLGHAIKQLWPHTKMAIGPVIDNGFYYDVDLDRTLTQEDVEAL
EKRMHELAEKNYDVIKKKVSWHEARETFANRGESYKVSILDENIAHDDKPGLYFHEEYVD
MCRGPHVPNMRFCHHFKLMKTAGAYWRGDSNNKMLQRIYGTAWADKKALNAYLQRLEEAA
KRDHRKIGKQLDLYHMQEEAPGMVFWHNDGWTIFRELEVFVRSKLKEYQYQEVKGPFMMD
RVLWEKTGHWDNYKDAMFTTSSENREYCIKPMNCPGHVQIFNQGLKSYRDLPLRMAEFGS
CHRNEPSGSLHGLMRVRGFTQDDAHIFCTEEQIRDEVNGCIRLVYDMYSTFGFEKIVVKL
STRPEKRIGSDEMWDRAEADLAVALEENNIPFEYQLGEGAFYGPKIEFTLYDCLDRAWQC
GTVQLDFSLPSRLSASYVGEDNERKVPVMIHRAILGSMERFIGILTEEFAGFFPTWLAPV
QVVIMNITDSQSEYVNELTQKLSNAGIRVKADLRNEKIGFKIREHTLRRVPYMLVCGDKE
VESGKVAVRTRRGKDLGSMDVNEVIEKLQQEIRSRSLKQLEE

# Drug_Target_1_Reaction:
ATP + L-threonine + tRNAThr = AMP + diphosphate + L-threonyl-tRNAThr

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
ThrS is also a translational repressor protein, it controls the translation of its own gene by binding to its mRNA

# Drug_Target_1_SwissProt_ID:
P0A8M5

# Drug_Target_1_SwissProt_Name:
SYT_SHIFL

# Drug_Target_1_Synonyms:
EC 6.1.1.3
ThrRS
Threonine--tRNA ligase

# Drug_Target_1_Theoretical_pI:
6.12

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasm

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
BA000033

# Drug_Target_2_GenBank_ID_Protein:
21204795

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
thrS

# Drug_Target_2_Gene_Sequence:
>1938 bp
CTATCTATGTTTTTTTAAACGAATTTCATCAACTAGATTCCAGATAAATTCATCTTTTTC
AACTGTTTCTTGGTCTTGCGATCCATATTGACGCACATTCACTTGATTATTTTCAACTTC
CTTATCCCCAACTACGATTTGATAAGGTATTTTTTGCATTTGAGCTTCTCTAATTTTATA
ACCCATTTTTTCATTACGGTCATCAATACTTACACGAACGCCTTGAGATTTCAATTCATC
TTGTAATTGGCGCGCATAATCATAATGTAAATCAACGTTAACTGGAATGATTTGAACTTG
TTTTGGCGCTAACCAAGTTGGGAATGCACCTTTAGTTTCTTCAGTTAAAAATGCTACAAA
TCGTTCCATTGTTGATACAACACCACGATGAATAACAACTGGACGATGATGTTCACCATC
TTGACCAATATAAGTTAAATCAAAACGTTCTGGTAATAAGAAATCAAGTTGTGCTGTTGA
TAATGTCTCTTCTTTACCCATCGCTGTTTTAACTTGAACATCTAGTTTCGGACCATAGAA
TGCCGCTTCACCAATCGCTTCTTCGTACGATAAGCCAAGCTCATCCGCTGCCTCTTTAAG
CATATTTTCAGCTTTATTCCACATATCATCATCATCAAAGTACTTTTCTTTATCTTCAGG
GTCTCTATAACTTAATCTAAAGCTATAATCCTCGAAACCAAAGTCTTTATACACATCAAT
AATCATGTTTACAACGCGTTTGAATTCTTCTTTAATTTGATCAGGTCGAACAAAGATATG
TGAATCATTTAAAGTCATACCACGAACACGTTGTAATCCTGATACAGCACCACTTGCTTC
ATATCTATGCATCGTTCCTAGCTCAGCGATACGGATAGGTAATTCACGATATGAATGTGG
TTTATTCGCATAAATCATCATATGATGTGGACAGTTCATTGGACGTAATACCATAGATTC
AGTTTCATCTAACTGCATTGGTGGGAACATATCTTCTTGATAGTGATCCCAGTGACCAGA
TGTTTTGTATAAATCAACATTAGCAAGTACTGGTGTATAAACGTGGTCATACCCCATGCT
CACCTCTTTATCAACAATGTAACGTTCAATTTCACGTCTAATTGTTGCACCGTTAGGTAA
CCATAATGGCAAACCAGCACCAACTAATTGGCTATTTGTGAATAATTCTAACTCTTTACC
AATTTTACGATGATCACGTTCTTTACGCTCTTCTAACATTTGTAAATGTGCTTTTAATTC
TTTTTTATCAAAGAAAGCAGTACCGTATATACGTTGTAACATTTTGTTGTTACTATCTCC
ACGCCAGTATGCACCTGCTGTAGATAATAGTTTAAACTCTTTAATTTTAGCTGTTGATGG
AACGTGAACTCCACGACATAAATCAGTAAAATCACCTTGACTATATAATGTTACATTTTC
ATCTTCAGGAATCGCGTCGATTAATTCTAATTTGTATTCATCATTGCTGAATAACTCTTT
CGCTTCATCTCGTGAAACCACTTTTCGTTCGATTTTCATATTTTCGTTAACGATTTGTTT
CATTGTCTTTTCAATTTGTTCAAAGTCATCAGATGAGATGTTTTGGTCAATGTCGAAGTC
ATAGTAGAATCCACCTTCTATTACAGGACCTACACCAAATTTAACATTACCATATAACCT
TTTAATCGCGTGTGCCATTAAATGTGCAGTAGAATGACGTAATACCTCTAACGCTTCTTC
ACTACCTGGTGTCACAATTTCAATTGATCCATCAGTTTCAAGCGGTTTTGTTAAATCTAC
AAGTTGCCCGTTAAATTTGCCGGCAACAGCTTTTTTACGTAATCCAGGACTAATTGATTG
TGCTATATCTTCAGTAGTAGTACCTTTATCAAACGCCTTTTTATTACCATCTGGAAATTG
AATATTAATTTGTTCCAT

# Drug_Target_2_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_2_General_References:
12044378	Baba T, Takeuchi F, Kuroda M, Yuzawa H, Aoki K, Oguchi A, Nagai Y, Iwama N, Asano K, Naimi T, Kuroda H, Cui L, Yamamoto K, Hiramatsu K: Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002 May 25;359(9320):1819-27.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
3508

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
74461

# Drug_Target_2_Name:
Threonyl-tRNA synthetase

# Drug_Target_2_Number_of_Residues:
645

# Drug_Target_2_PDB_ID:
1NYR

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00587	tRNA-synt_2b
PF02824	TGS
PF03129	HGTP_anticodon
PF07973	tRNA_SAD

# Drug_Target_2_Protein_Sequence:
>Threonyl-tRNA synthetase
MEQINIQFPDGNKKAFDKGTTTEDIAQSISPGLRKKAVAGKFNGQLVDLTKPLETDGSIE
IVTPGSEEALEVLRHSTAHLMAHAIKRLYGNVKFGVGPVIEGGFYYDFDIDQNISSDDFE
QIEKTMKQIVNENMKIERKVVSRDEAKELFSNDEYKLELIDAIPEDENVTLYSQGDFTDL
CRGVHVPSTAKIKEFKLLSTAGAYWRGDSNNKMLQRIYGTAFFDKKELKAHLQMLEERKE
RDHRKIGKELELFTNSQLVGAGLPLWLPNGATIRREIERYIVDKEVSMGYDHVYTPVLAN
VDLYKTSGHWDHYQEDMFPPMQLDETESMVLRPMNCPHHMMIYANKPHSYRELPIRIAEL
GTMHRYEASGAVSGLQRVRGMTLNDSHIFVRPDQIKEEFKRVVNMIIDVYKDFGFEDYSF
RLSYRDPEDKEKYFDDDDMWNKAENMLKEAADELGLSYEEAIGEAAFYGPKLDVQVKTAM
GKEETLSTAQLDFLLPERFDLTYIGQDGEHHRPVVIHRGVVSTMERFVAFLTEETKGAFP
TWLAPKQVQIIPVNVDLHYDYARQLQDELKSQGVRVSIDDRNEKMGYKIREAQMQKIPYQ
IVVGDKEVENNQVNVRQYGSQDQETVEKDEFIWNLVDEIRLKKHR

# Drug_Target_2_Reaction:
ATP + L-threonine + tRNAThr = AMP + diphosphate + L-threonyl-tRNAThr

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
ATP + L-threonine + tRNA(Thr) = AMP + diphosphate + L-threonyl-tRNA(Thr)

# Drug_Target_2_SwissProt_ID:
Q8NW68

# Drug_Target_2_SwissProt_Name:
SYT_STAAW

# Drug_Target_2_Synonyms:
EC 6.1.1.3
ThrRS
Threonine--tRNA ligase

# Drug_Target_2_Theoretical_pI:
5.04

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB03355
